Technological breakthroughs in vector engineering, manufacturing platforms, and delivery systems are fundamentally transforming the AAV Vector-Based Gene Therapy Market, enabling researchers to develop more effective, targeted, and scalable therapies. The development of next-generation AAV vectors with enhanced tissue specificity and reduced immunogenicity is expanding the therapeutic...